Analysts set PT The Cooper Companies, Inc. (NASDAQ:COO) at $113.61

Shares of The Cooper Companies, Inc. (NASDAQ:COO – Get Free Report ) has received an average recommendation of “Moderate Buy” from the thirteen ratings firms that are covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $113.61.

A number of research analysts have recently issued reports on COO shares. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research report on Thursday, August 29th. Stifel Nicolaus reissued a “buy” rating and set a $115.00 price objective (up previously from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Jefferies Financial Group raised Cooper Companies from a “hold” rating to a “buy” rating and upped their price target for the company from $107.00 to $115.00 in a research report on Tuesday , July 16. Piper Sandler upped their target price on Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Finally, Wells Fargo & Company boosted their price objective on Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a report on Thursday, August 29th.

Check out our latest report on Cooper Companies

Insider Buying and Selling at Cooper Companies

In other news, CFO Brian G. Andrews sold 24,788 shares of the business’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $105.90, for a total value of $2,625,049.20. Following the completion of the sale, the chief financial officer now owns 6,614 shares in the company, valued at approximately $700,422.60. The transaction was disclosed in a filing with the SEC, which is accessible via this hyperlink. In related news, COO Daniel G. Mcbride sold 114,992 shares of Cooper Companies stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the sale, the chief operating officer now directly owns 44,696 shares in the company, valued at $4,714,534.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible via this hyperlink. Also, CFO Brian G. Andrews sold 24,788 shares of the business’s stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $105.90, for a total value of $2,625,049.20. Following the completion of the transaction, the chief financial officer now directly owns 6,614 shares in the company, valued at approximately $700,422.60. The disclosure for this sale can be found here. Company insiders hold 2.00% of the company’s shares.

Institutional Investors Weigh On Cooper Companies

A number of hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. boosted its holdings in shares of Cooper Companies by 303.0% in the first quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock worth $2,343,723,000 after acquiring an additional 17,367,502 shares during the period. Kayne Anderson Rudnick Investment Management LLC lifted its position in shares of Cooper Companies by 3.0% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 7,820,590 shares of the medical device company’s stock valued at $682,738,000 after purchasing an additional 231,155 shares in the last quarter. Capital World Investors raised its stake in shares of Cooper Companies by 301.7% in the first quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock worth $573,657,000 after acquiring an additional 4,246,519 shares during the period. Janus Henderson Group PLC raised its stake in shares of Cooper Companies by 279.8% in the first quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock worth $348,723,000 after acquiring an additional 2,532,186 shares during the period. Finally, Impax Asset Management Group plc boosted its holdings in Cooper Companies by 31.0% in the second quarter. Impax Asset Management Group plc now owns 2,359,798 shares of the medical device company’s stock worth $205,511,000 after purchasing an additional 558,886 shares in the last quarter. 24.39% of shares are currently owned by institutional investors.

Cooper Companies shares rose 0.1%

Shares of NASDAQ:COO opened at $106.59 on Friday. Cooper Companies has a 1 year low of $75.93 and a 1 year high of $107.82. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.99, and a quick ratio of 1.14. The company’s 50-day moving average is $93.30 and its 200-day moving average is $94.62. The company has a market cap of $21.22 billion, a price-to-earnings ratio of 62.70, a P/E/G ratio of 2.56 and a beta of 0.98.

Cooper Companies (NASDAQ:COO – Get Free Report ) last posted its quarterly earnings results on Wednesday, August 28th. The medical devices company reported $0.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.05. The firm had revenue of $1 billion for the quarter, compared to analyst estimates of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The company’s revenue was up 7.8% compared to the same quarter last year. In the same period last year, the firm earned $0.84 per share. equities research analysts predict that Cooper Companies will post 3.66 earnings per share for the current year.

About Cooper Companies

(Get a free report

Cooper Companies, Inc, together with its subsidiaries, develops, manufactures and markets contact lens wearers. The company operates through two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lenses, including lenses that correct myopia and hyperopia; and toric and multifocal lenses comprising lenses that correct vision problems such as astigmatism, presbyopia and myopia in the Americas, Europe, the Middle East, Africa and Asia Pacific.

Featured stories

Get daily news and ratings for Cooper companies – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Cooper Companies and related companies with MarketBeat.com’s FREE daily email newsletter.